{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:22:23Z","timestamp":1788333743804,"version":"build-2803163510"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,11,25]]},"DOI":"10.1253\/circj.cj-25-0087","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:07:53Z","timestamp":1747246073000},"page":"1940-1946","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Stent Strategy and Drug-Coated Balloon After JETSTREAM for Severely Calcified Femoropopliteal Artery Disease (CORVUS Study)"],"prefix":"10.1253","volume":"89","author":[{"given":"Takahiro","family":"Tokuda","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya Heart Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sendai Kousei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saiseikai Yokohama City Eastern Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rakuwakai Otowa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Takei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tenyoukai Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tokuda T, Hirano K, Takemura A, Oba Y. Utility and safety of a novel method using a Wingman catheter for patients with lower extremity arterial disease complicated with severely calcified lesions: Wingman\u2019s bevel tip inner catheter removal technique - a prospective cohort study. <i>Health Sci Rep<\/i> 2023; 6: e1586.","DOI":"10.1002\/hsr2.1586"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kurata N, Iida O, Asai M, Okamoto S, Ishihara T, Nanto K, et al. Factors in sufficient endovascular vessel preparation for severely calcified femoropopliteal lesions. <i>Circ J<\/i> 2023; 87: 424\u2013431.","DOI":"10.1253\/circj.CJ-22-0444"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mori S, Hirano K, Setonaga Y, Kishida T, Fukagawa T, Yamaguchi K, et al. Investigation of the feasibility and safety of a highly intensive penetration technique for recanalization in severe calcified femoropopliteal occlusive lesions: A retrospective observational study. <i>Health Sci Rep<\/i> 2025; 8: e70391.","DOI":"10.1002\/hsr2.70391"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Iida O, Takahara M, Soga Y, Yamaoka T, Nanto S, Kuratani T, et al. One-year outcomes of heparin-bonded stent-graft therapy for real-world femoropopliteal lesions and the association of patency with the prothrombotic state based on the prospective, observational, multicenter Viabahn stent-graft placement for femoropopliteal diseases requiring endovascular therapy (VANQUISH) study. <i>J Endovasc Ther<\/i> 2021; 28: 123\u2013131.","DOI":"10.1177\/1526602820960445"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Iida O, Takahara M, Soga Y, Yamaoka T, Fujihara M, Kawasaki D, et al. 1-Year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: Predictors of restenosis and aneurysmal degeneration. <i>JACC Cardiovasc Interv<\/i> 2022; 15: 630\u2013638.","DOI":"10.1016\/j.jcin.2022.01.019"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fujihara M, Takahara M, Iida O, Kawasaki D, Soga Y, Tobita K, et al. Endovascular therapy with interwoven nitinol stent placement after predilation for heavily calcified femoropopliteal artery disease: Results of the BURDOCK study. <i>J Vasc Interv Radiol<\/i> 2023; 34: 1929\u20131937.","DOI":"10.1016\/j.jvir.2023.07.023"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, et al. Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. <i>J Am Heart Assoc<\/i> 2023; 12: e025677.","DOI":"10.1161\/JAHA.122.025677"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Iida O, Urasawa K, Shibata Y, Yamamoto Y, Ando H, Fujihara M, et al. Clinical safety and efficacy of rotational atherectomy in Japanese patients with peripheral arterial disease presenting femoropopliteal lesions: The J-SUPREME and J-SUPREME II trials. <i>J Endovasc Ther<\/i> 2022; 29: 240\u2013247.","DOI":"10.1177\/15266028211045700"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: Prevalence, mechanism, detection, and clinical implications. <i>Catheter Cardiovasc Interv<\/i> 2014; 83: E212\u2013E220.","DOI":"10.1002\/ccd.25387"},{"key":"10","unstructured":"10. Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. <i>Eur J Vasc Endovasc Surg<\/i> 2019; 58(Suppl): S1\u2013S109.e33."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ranke C, Creutzig A, Alexander K. Duplex scanning of the peripheral arteries: Correlation of the peak velocity ratio with angiographic diameter reduction. <i>Ultrasound Med Biol<\/i> 1992; 18: 433\u2013440.","DOI":"10.1016\/0301-5629(92)90082-L"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. <i>Pharm Stat<\/i> 2011; 10: 150\u2013161.","DOI":"10.1002\/pst.433"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gray WA, Garcia LA, Amin A, Shammas NW; JET Registry Investigators. Jetstream atherectomy system treatment of femoropopliteal arteries: Results of the post-market JET Registry. <i>Cardiovasc Revasc Med<\/i> 2018; 19: 506\u2013511.","DOI":"10.1016\/j.carrev.2017.12.015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shammas NW, Purushottam B, Shammas WJ, Christensen L, Shammas G, Weakley D, et al. Jetstream atherectomy followed by paclitaxel-coated balloons versus balloon angioplasty followed by paclitaxel-coated balloons: Twelve-month exploratory results of the prospective randomized JET-RANGER study. <i>Vasc Health Risk Manag<\/i> 2022; 18: 603\u2013615.","DOI":"10.2147\/VHRM.S371177"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Taneva GT, Pitoulias AG, Avranas K, Kazemtash M, Bakr NA, Dahi F, et al. Midterm outcomes of rotational atherectomy-assisted endovascular treatment of severe peripheral arterial disease. <i>J Vasc Surg<\/i> 2024; 79: 887\u2013892.","DOI":"10.1016\/j.jvs.2023.12.030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. <i>J Am Coll Cardiol<\/i> 2012; 59: 16\u201323.","DOI":"10.1016\/j.jacc.2011.09.036"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tsujimura T, Iida O, Ishihara T, Asai M, Masuda M, Okamoto S, et al. Angioscopic evaluation of vascular response after fluoropolymer-based drug-eluting stent implantation for femoropopliteal artery lesions. <i>Circ J<\/i> 2023; 87: 432\u2013439.","DOI":"10.1253\/circj.CJ-22-0635"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ogata K, Nishihira K, Asano Y, Honda Y, Yamamoto K, Emori H, et al. Clinical comparison of drug-coated balloon and drug-eluting stent for femoropopliteal lesions in chronic limb-threatening ischemia with wounds. <i>Circ J<\/i> 2024; 88: 1647\u20131655.","DOI":"10.1253\/circj.CJ-24-0176"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Min A, Alkhalifa F, Ahrari A, Healy G, Jaberi A, Tan KT, et al. Insights from the FDA\u2019s MAUDE database regarding the real-world safety of Jetstream atherectomy for peripheral arterial disease. <i>J Endovasc Ther<\/i> 2025; 32: 1067\u20131074.","DOI":"10.1177\/15266028231202718"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sharis EM, Shammas NW, Shammas GA, Jones-Miller S. WIRION EPS filter with Jetstream atherectomy of femoropopliteal arterial disease: A single center experience. <i>Cardiovasc Revasc Med<\/i> 2020; 21: 96\u201399.","DOI":"10.1016\/j.carrev.2018.11.014"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Zeller T, Langhoff R, Rocha-Singh KJ, Jaff MR, Blessing E, Amann-Vesti B, et al. Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: Twelve-month results of the DEFINITIVE AR study. <i>Circ Cardiovasc Interv<\/i> 2017; 10: e004848.","DOI":"10.1161\/CIRCINTERVENTIONS.116.004848"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hu L, Wang H, Pan D, Wu S, Zhang H, Gu Y. Three-year results of combining debulking devices with drug-coated balloons for the treatment of de novo femoropopliteal arteriosclerosis obliterans. <i>Ann Vasc Surg<\/i> 2025; 114: 63\u201373.","DOI":"10.1016\/j.avsg.2025.01.019"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stavroulakis K, Bisdas T, Torsello G, Tsilimparis N, Damerau S, Argyriou A. Intravascular lithotripsy and drug-coated balloon angioplasty for severely calcified femoropopliteal arterial disease. <i>J Endovasc Ther<\/i> 2023; 30: 106\u2013113.","DOI":"10.1177\/15266028221075563"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Armstrong EJ, Adams G, Soukas PA, Mangalmurti SS, Shammas NW, Mehrle A, et al. Intravascular lithotripsy for peripheral artery calcification: 30-day outcomes from the Disrupt PAD III observational study. <i>J Endovasc Ther<\/i> 2024, doi:10.1177\/15266028241283716.","DOI":"10.1177\/15266028241283716"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/12\/89_CJ-25-0087\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:15:32Z","timestamp":1764386132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/12\/89_CJ-25-0087\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0087","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"article-number":"CJ-25-0087"}}